Literature DB >> 11859395

Weight loss and malnutrition in patients with chronic graft-versus-host disease.

D A Jacobsohn1, J Margolis, J Doherty, V Anders, G B Vogelsang.   

Abstract

It is well known that weight loss occurs in patients with chronic graft-versus-host disease. However, the severity and frequency of weight loss in this population have not been adequately described. Recent data suggest that a body-mass index (BMI) below 21.9 is an independent risk factor for mortality. In our analysis we have shown that out of 93 patients with cGVHD, 43% are malnourished as evidenced by a BMI less than 21.9 and 14% are severely malnourished (BMI less than 18.5). In addition, there is a clear trend showing that patients with active, ongoing cGVHD have lower BMIs (P = 0.02). Furthermore, we show that many symptoms thought to contribute to weight loss in patients with cGVHD, such as odynophagia and oral sensitivity, are not related to weight loss in our population. We conclude that, in all likelihood, unknown causes still exist that are responsible for weight loss in this group of patients. Elevated resting energy expenditure and elevated serum tumor necrosis factor-alpha are potential contributors to weight loss that will be tested in future studies. We also conclude that treating cGVHD aggressively may help reverse weight loss and malnutrition, which may be independent risk factors for mortality in this population.

Entities:  

Mesh:

Year:  2002        PMID: 11859395     DOI: 10.1038/sj.bmt.1703352

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN: 0268-3369            Impact factor:   5.483


  19 in total

1.  Body composition after bone marrow transplantation in childhood.

Authors:  Kathy Ruble; Matthew Hayat; Kerry J Stewart; Allen Chen
Journal:  Oncol Nurs Forum       Date:  2012-03       Impact factor: 2.172

2.  Salivary gland involvement in chronic graft-versus-host disease: prevalence, clinical significance, and recommendations for evaluation.

Authors:  Matin M Imanguli; Jane C Atkinson; Sandra A Mitchell; Daniele N Avila; Rachel J Bishop; Edward W Cowen; Manuel B Datiles; Frances T Hakim; David E Kleiner; Michael C Krumlauf; Steven Z Pavletic
Journal:  Biol Blood Marrow Transplant       Date:  2010-03-28       Impact factor: 5.742

3.  Risk factors associated with increased nonrelapse mortality and with poor overall survival in children with chronic graft-versus-host disease.

Authors:  David A Jacobsohn; Mukta Arora; John P Klein; Anna Hassebroek; Mary E Flowers; Corey S Cutler; Alvaro Urbano-Ispizua; Brian J Bolwell; Joseph H Antin; Michael Boyiadzis; Jean-Yves Cahn; Mitchell S Cairo; Roger H Herzig; Luis M Isola; Thomas R Klumpp; Stephanie J Lee; Effie W Petersdorf; Stella Santarone; Robert P Gale; Harry C Schouten; Stephen R Spellman; Daniel J Weisdorf; John R Wingard; Mary M Horowitz; Steven Z Pavletic
Journal:  Blood       Date:  2011-08-30       Impact factor: 22.113

4.  Malnutrition in patients with chronic GVHD.

Authors:  C W Bassim; H Fassil; M Dobbin; S M Steinberg; K Baird; K Cole; G Joe; L E Comis; S A Mitchell; L Grkovic; D Edwards; J W Mays; E W Cowen; D Pulanic; K M Williams; R E Gress; S Z Pavletic
Journal:  Bone Marrow Transplant       Date:  2014-07-14       Impact factor: 5.483

5.  National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: V. The 2014 Ancillary Therapy and Supportive Care Working Group Report.

Authors:  Paul A Carpenter; Carrie L Kitko; Sharon Elad; Mary E D Flowers; Juan C Gea-Banacloche; Jörg P Halter; Flora Hoodin; Laura Johnston; Anita Lawitschka; George B McDonald; Anthony W Opipari; Bipin N Savani; Kirk R Schultz; Sean R Smith; Karen L Syrjala; Nathaniel Treister; Georgia B Vogelsang; Kirsten M Williams; Steven Z Pavletic; Paul J Martin; Stephanie J Lee; Daniel R Couriel
Journal:  Biol Blood Marrow Transplant       Date:  2015-03-31       Impact factor: 5.742

6.  Measuring therapeutic response in chronic graft-versus-host disease. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: IV. The 2014 Response Criteria Working Group report.

Authors:  Stephanie J Lee; Daniel Wolff; Carrie Kitko; John Koreth; Yoshihiro Inamoto; Madan Jagasia; Joseph Pidala; Attilio Olivieri; Paul J Martin; Donna Przepiorka; Iskra Pusic; Fiona Dignan; Sandra A Mitchell; Anita Lawitschka; David Jacobsohn; Anne M Hall; Mary E D Flowers; Kirk R Schultz; Georgia Vogelsang; Steven Pavletic
Journal:  Biol Blood Marrow Transplant       Date:  2015-03-19       Impact factor: 5.742

7.  Longitudinal changes in body mass and composition in survivors of childhood hematologic malignancies after allogeneic hematopoietic stem-cell transplantation.

Authors:  Hiroto Inaba; Jie Yang; Sue C Kaste; Christine M Hartford; Megan S Motosue; Wassim Chemaitilly; Brandon M Triplett; David R Shook; Ching-Hon Pui; Wing Leung
Journal:  J Clin Oncol       Date:  2012-10-01       Impact factor: 44.544

Review 8.  Graft-versus-host disease (GvHD) of the tongue and of the oral cavity: a large retrospective study.

Authors:  Andrea Piccin; Mario Tagnin; Cinzia Vecchiato; Ahmad Al-Khaffaf; Lisa Beqiri; Caroline Kaiser; Iris Agreiter; Giovanni Negri; Michael Kob; Angela Di Pierro; Fabio Vittadello; Guido Mazzoleni; Klaus Eisendle; Fabrizio Fontanella
Journal:  Int J Hematol       Date:  2018-08-24       Impact factor: 2.490

9.  Oral manifestations in the Graft versus Host Disease in paediatric patients: case report.

Authors:  P Maturo; R Condò; M Costacurta; R Docimo
Journal:  Oral Implantol (Rome)       Date:  2010-03-04

Review 10.  Oral chronic graft-versus-host disease: current pathogenesis, therapy, and research.

Authors:  J W Mays; H Fassil; D A Edwards; S Z Pavletic; C W Bassim
Journal:  Oral Dis       Date:  2012-10-28       Impact factor: 3.511

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.